• Focused Nano-Permeabilization (FORN) technology etc. for targeted, precise cancer drug delivery.
• HAEMOSEIS-256, a non-invasive cardiovascular diagnostic device that provides a comprehensive assessment (3D Cartography with 3D Vasculography) of cardiopulmonary and renal physiology of an individual
• SPARSE™ technology for fuel enrichment and its application in renewable energy production
• Fluid Ignition Engine (FIT), the TMD reactor for high intensity megasonic break-down of long chain hydrocarbons.
• Transcutaneous Thermoelectroporic Omni-molecular drug delivery systems

The Shycocan device was built in early 2018, nearly two years prior to the COVID-19 pandemic. While working for over five years on another patent, Dr. Kumar developed a highly specialized alloy that produced Photons in 2016. The trigger of building the device was a Bird Flu pandemic that resulted in many poultry farmers going bankrupt at the end of 2017. The Bird Flu virus belongs to the Influenza family, hence these devices were installed at Dr. Kumar’s campus to test their efficacy on stopping the transmission of the virus. It was observed at the end of 2018 that there was a reduction of ninety percent in the incidence of seasonal flu’s amongst employees over the previous two years. This device was then tested post the COVID-19 pandemic in accredited laboratories for safety and efficacy.  It was seen that it disabled the Coronavirus and Influenza viruses by 99.9% in closed spaces as per the result. COVID-19 has a similar Postive-Sense S-protein structure to the Bird Flu and Seasonal Flu virus. The device was named Scalene HYpercharge COrona CANon “ Shycocan” post the pandemic.

Shycocan is a certified European Union CE Class-I product and is being marketed under the “Enforcement Discretion Guidance” based on the US FDA’s guidance during the  COVID-19 Pandemic/ Public Health Emergency. It has passed all safety tests related to these certifications for household appliances, emission, disturbances, laboratory use, Ozone production amongst others. Shycocan attenuates 99.9% of the Coronavirus from transmission in closed spaces as per tests conducted by a leading virology lab in the world.

The Coronavirus is a Positive-Sense virus, whose S-Protein attaches to the human cell through the ACE2 receptors due to the opposite charge. All human cells have a negative potential (about -40mV to -70mV). The virus infuses its RNA into the cells and starts to multiply, infecting the body. Shycocan continuously emits photons that form an electron cloud in an indoor space. The negative charged electrons neutralize the positive charge of the S-Protein of Coronavirus, thereby disabling it from infecting a person.

Shycocan does not kill the Coronavirus. The device attenuates the virus due to the unique action of neutralizing its charge on the Spike Protein (S-Protein) of the virus.